In vivo stimulation of I kappa B phosphorylation is not sufficient to activate NF-kappa B
about
Regulation of IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophagesEdible blue-green algae reduce the production of pro-inflammatory cytokines by inhibiting NF-κB pathway in macrophages and splenocytesImpairment of NF-kB activation and modulation of gene expression by calpastatinRegulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator activity by I kappa B kinase.Direct involvement of the ubiquitin-conjugating enzyme Ubc9/Hus5 in the degradation of IkappaBalphaIkappaB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complexI kappaB alpha physically interacts with a cytoskeleton-associated protein through its signal response domainMapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradationRegulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factorsTransdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplicationDual effects of IkappaB kinase beta-mediated phosphorylation on p105 Fate: SCF(beta-TrCP)-dependent degradation and SCF(beta-TrCP)-independent processingIKK-i and TBK-1 are enzymatically distinct from the homologous enzyme IKK-2: comparative analysis of recombinant human IKK-i, TBK-1, and IKK-2Ubiquitination and degradation of the inhibitors of NF-kappaBThe physical association of casein kinase 2 with nucleolinABIN-2 is required for optimal activation of Erk MAP kinase in innate immune responsesCD40 regulates the processing of NF-kappaB2 p100 to p52Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathwayAll three IkappaB isoforms and most Rel family members are stably associated with the IkappaB kinase 1/2 complexCritical role for lysines 21 and 22 in signal-induced, ubiquitin-mediated proteolysis of I kappa B-alphaSignal-induced degradation of I(kappa)B(alpha): association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not requiredCaprin-1 is a target of the deafness gene Pou4f3 and is recruited to stress granules in cochlear hair cells in response to ototoxic damage.Bridging the gap: composition, regulation, and physiological function of the IkappaB kinase complex.How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex.Synergistic protection of combined probiotic conditioned media against neonatal necrotizing enterocolitis-like intestinal injury.A requirement for NF-kappaB activation in Bcr-Abl-mediated transformationAn essential role for nuclear factor kappaB in promoting double positive thymocyte apoptosis.The in vivo function of a noncanonical TRAF2-binding domain in the C-terminus of CD40 in driving B-cell growth and differentiationChronic human immunodeficiency virus type 1 infection of myeloid cells disrupts the autoregulatory control of the NF-kappaB/Rel pathway via enhanced IkappaBalpha degradationN- and C-terminal sequences control degradation of MAD3/I kappa B alpha in response to inducers of NF-kappa B activity.Constitutive phosphorylation of IkappaBalpha by casein kinase II occurs preferentially at serine 293: requirement for degradation of free IkappaBalpha.Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms.Bid Promotes K63-Linked Polyubiquitination of Tumor Necrosis Factor Receptor Associated Factor 6 (TRAF6) and Sensitizes to Mutant SOD1-Induced Proinflammatory Signaling in Microglia.Participation of mammalian target of rapamycin complex 1 in Toll-like receptor 2- and 4-induced neutrophil activation and acute lung injury.Inhibition of bovine endothelial cell activation in vitro by regulated expression of a transdominant inhibitor of NF-kappa B.Liver kinase B1 is required for thromboxane receptor-dependent nuclear factor-κB activation and inflammatory responses.Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires.Bioactive compounds with effects on inflammation markers in humans.It takes two to tango: IκBs, the multifunctional partners of NF-κB.Regulation of NF-κB by ubiquitination and degradation of the IκBs.I kappaB alpha-independent downregulation of NF-kappaB activity by glucocorticoid receptor.
P2860
Q21296830-B1AC4F9B-29CD-4B49-8F61-BF58DE021A6CQ21994486-7D727AE2-8E1A-43A1-86B7-177E2425E166Q23923192-446FFB5D-B778-4AE6-A9D6-EF474F1E585EQ24295084-41E775E5-F278-43A9-AB87-CA12FDD2ABF3Q24317303-ED3C9F48-0F72-4942-9090-134FA2B56945Q24530641-D29A107F-E51E-4628-993C-ECBE1DBC641EQ24643936-B3FA9CCC-5B46-4DC3-BDA1-FCE20FE56114Q24650561-3C26E848-33E2-45E8-A051-01368B879DA0Q24651506-7754D557-6509-4274-AA07-A871B9C84454Q24681560-166A7D28-B986-4868-AA94-2481EAD5DE5DQ28114844-6276E27E-C59B-473C-B4E0-8D43EAE7E5BCQ28198356-5B7597F1-6E02-4328-B15C-07F7C08FD664Q28274205-5A36D50B-FAA1-421E-963A-3159A52F241AQ28282040-96C97A2E-E5C3-45CA-8949-9A1DACF4FD41Q28585458-E58EB9DA-3C34-4A58-9050-8CC80F45E107Q28610678-139F10C4-2F6C-4B1B-8554-DFA4606479DBQ28615591-BD44958C-D5B2-492B-82DD-DF100A01E639Q28616457-42D6C6A8-6C6D-4F67-B521-9D1186884300Q28618972-2A1588DB-F3EC-4567-8049-D9D0536C865EQ28776784-54FC783C-70C0-44BC-BA1C-71BEA688FF0DQ30498633-2306F177-6791-4354-97C8-1295D58D4B75Q33663188-B3DD7827-D1A5-4CCC-A380-A38490D0D7A6Q33797139-0DEBA9C7-1B13-4156-B972-8B7954F2FCBEQ34746651-3D00E23A-4211-4CF9-8B1E-3C3769E37500Q35195588-48F1E3FD-F4F7-4146-B307-B2744628EF3DQ35834615-89C1C14E-CC9B-476B-A1B5-D71E1BBF5E1FQ35850668-6041453F-7386-4ECF-B861-D64E10282520Q35865967-58D15C1F-EDB3-47B9-9926-3FEC13C6CCBEQ36555088-EF130D60-8DE3-42FC-8DE0-75E049115594Q36560731-57D1BCD1-D570-464E-ABDD-BDF9B4602E6FQ36634373-39191FF5-0380-428C-9846-2E632EADEDECQ36909735-E59D9560-0167-4068-B93A-8F27ABEF2224Q37275496-BC5ECFE1-512B-46E8-B399-89C47F06E601Q37363570-CB8D269B-00BD-43F8-BAB0-ADCDB2E951B9Q37405459-EBCAD0E1-47CC-46C3-8322-03CD2C847970Q37689611-9E0D3F62-B272-4014-9F35-FA8D944299A7Q37976087-A879E5EC-DAEF-407D-93A9-B32E339FE7D9Q37995679-6B336C8C-2A30-4249-8BE9-AB58E39437C9Q37995680-2C076C1B-938B-4DF0-9791-600A5FC85820Q38343666-08CF9C0E-2CFF-4F43-995C-78C3D4D23B25
P2860
In vivo stimulation of I kappa B phosphorylation is not sufficient to activate NF-kappa B
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
In vivo stimulation of I kappa B phosphorylation is not sufficient to activate NF-kappa B
@ast
In vivo stimulation of I kappa B phosphorylation is not sufficient to activate NF-kappa B
@en
type
label
In vivo stimulation of I kappa B phosphorylation is not sufficient to activate NF-kappa B
@ast
In vivo stimulation of I kappa B phosphorylation is not sufficient to activate NF-kappa B
@en
prefLabel
In vivo stimulation of I kappa B phosphorylation is not sufficient to activate NF-kappa B
@ast
In vivo stimulation of I kappa B phosphorylation is not sufficient to activate NF-kappa B
@en
P2093
P2860
P356
P1476
In vivo stimulation of I kappa B phosphorylation is not sufficient to activate NF-kappa B
@en
P2093
A Hatzubai
I Pashut-Lavon
Y Ben-Neriah
P2860
P304
P356
10.1128/MCB.15.3.1294
P407
P577
1995-03-01T00:00:00Z